Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »
Sanofi said Wednesday it will sell monthly supplies of insulin for a fixed price of $ 99 for patients paying with cash in the U.S. as the pharmaceutical giant faces intense pressure from the Trump administration and Congress to lower the cost of its nearly 100-year-old, life-saving medication.
Pop superstar Taylor Swift’s former West Village rental has finally found a buyer — at less than half its original asking price. Swift loved the charming carriage house at 23 Cornelia Street enough to rent it for $ 39,500 a month back in 2016, when she was renovating part of her $ 50 million compound… Read More »
By SOMALARAM VENKATESH MD With a stated intent of bringing social justice and financial relief to hundreds of thousands of patients undergoing coronary angioplasty in the country every year, the Government of India capped the sale price of coronary stents in Feb 2017. Stent prices fell by as much as 80% with this populist move,… Read More »
On Dec. 10, Bristol-Myers Squibb made what it said was its final offer to acquire Celgene. But it turns out that wasn’t the case. It ended up scoring a better deal instead. Just days before a Jan. 2 deadline Bristol-Myers itself had set for wrapping up an agreement, the New Jersey drugmaker pulled that proposal—$ 57… Read More »
In April 2018, the Centers for Medicare and Medicaid Services (CMS – Medicare) issued a draft rule intended, generally, to nudge health systems toward several initiatives. These included improving the use of electronic health records and IT interoperability, providing greater price transparency of services, and empowering physicians to spend more time with their patients. This… Read More »